Research Article
Serum miR-375 Levels Are Closely Related to Disease Progression from HBV Infection to HBV-Related Hepatocellular Carcinoma
Table 1
Relationship between serum miR-375 levels and HBV serological markers in the HBV-infected patients (
(%)).
| | HBV serological markers | Number of patients (%) | miR-375 levels | value | |
| | Anti-HBs | | | 0.662 | 0.509 | | Positive | 2 (1.46%) | | | | | Negative | 135 (98.54%) | | | | | HBeAg | | | 2.037 | 0.044 | | Positive | 54 (39.42%) | | | | | Negative | 83 (60.58%) | | | | | Anti-HBe | | | 2.174 | 0.032 | | Positive | 56 (40.88%) | | | | | Negative | 81 (59.12%) | | | | | Anti-HBc | | | 0.961 | 0.339 | | Positive | 127 (92.70%) | | | | | Negative | 10 (7.30%) | | | | | HBV DNA | | | 2.022 | 0.046 | | Positive | 62 (45.26%) | | | | | Negative | 75 (54.74%) | | | |
|
|
Serum HBV copies/mL was defined as HBV DNA-positive. Serum HBV copies/mL was defined HBV DNA-negative. . |